why choose us

First received: November 04, 2024

Clinical Trial: Investigation of Pharmacokinetics,Safety,and Pharmacodynamics of HRS-5965 in Subjects With Hepatic Impairment

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Complement Mediated Primary or Secondary Glomerular Diseases

Study Type: INTERVENTIONAL


Official Title: A Single-dose, Open-label, Phase I Study Comparing the Pharmacokinetics, Safety, and Pharmacodynamics of HRS-5965 in Subjects With Mild and Moderate Hepatic Impairment and Normal Hepatic Function

Brief Summary: The study is being conducted to compare the pharmacokinetics, safety, and pharmacodynamics of HRS-5965 in subjects with mild to moderate hepatic impairment and normal hepatic function.

Read more